Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by

In a recent study published in Leukemia, Finnish researchers investigated why some patients with chronic myeloid leukemia (CML) can discontinue their daily medication safely.

Leave A Comment

Your email address will not be published. Required fields are marked *